关注
Faizan Khan
Faizan Khan
在 uic.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Non-invasive strategies for nose-to-brain drug delivery
JT Trevino, RC Quispe, F Khan, V Novak
Journal of clinical trials 10 (7), 2020
812020
MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial
V Novak, CS Mantzoros, P Novak, R McGlinchey, W Dai, V Lioutas, ...
Journal of neurology 269 (9), 4817-4835, 2022
292022
Use of radiofrequency ablation for the management of facial pain: a systematic review
V Orhurhu, F Khan, RC Quispe, L Huang, I Urits, M Jones, O Viswanath, ...
Pain Physician 23 (6), E559, 2020
202020
Patient satisfaction following intrathecal targeted drug delivery for benign chronic pain: results of a single-center survey study
DM Schultz, V Orhurhu, F Khan, JM Hagedorn, A Abd-Elsayed
Neuromodulation: Technology at the Neural Interface 23 (7), 1009-1017, 2020
172020
Use of radiofrequency ablation for the management of headache: a systematic review
V Orhurhu, L Huang, RC Quispe, F Khan, J Karri, I Urits, J Hasoon, ...
Pain Physician 24 (7), E973, 2021
132021
Safety of intranasal insulin in type 2 diabetes on systemic insulin: a double-blinded placebo-controlled sub-study of memaid trial
LA Becerra, BG Mendez, F Khan, V Lioutas, P Novak, CS Mantzoros, ...
Archives of diabetes & obesity 4 (2), 403, 2022
32022
Daily intranasal insulin at 40IU does not affect food intake and body composition: A placebo-controlled trial in older adults over a 24-week period with 24-weeks of follow-up
LA Becerra, A Gavrieli, F Khan, P Novak, V Lioutas, LH Ngo, V Novak, ...
Clinical Nutrition 42 (6), 825-834, 2023
22023
Obesity trends amongst hospitalized patients with spinal cord stimulator implants
V Orhurhu, F Khan, M Salisu Orhurhu, E Agudile, I Urits, J Hasoon, ...
Advances in Therapy 37, 4614-4626, 2020
22020
Intranasal Insulin Enhances Resting Neurovascular Fluctuations in Type 2 Diabetes
Z Zhang, F Khan, P Novak, C Mantzoros, L Ngo, V Novak, W Dai
1
Dropout risk and effectiveness of retention strategies in the Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID) Clinical Trial
DF Isaza-Pierrotti, F Khan, P Novak, V Lioutas, CS Mantzoros, LH Ngo, ...
Contemporary clinical trials 125, 107057, 2023
2023
193-OR: Memory Advancement with Intranasal Insulin in Type 2 Diabetes: Randomized Control Trial
V Novak, C Mantzoros, P Novak, R McGlinchey, W Dai, V Lioutas, S Buss, ...
Diabetes 70 (Supplement_1), 2021
2021
879-P: Dropout Risk and Effectiveness of Retention Strategies: A Substudy of the Memory Advancement by Intranasal Insulin (INI) in Type 2 Diabetes (MemAID)
F Khan, DF Isaza-Pierotti, P Novak, C Mantzoros, LH Ngo, V Novak
Diabetes 70 (Supplement_1), 2021
2021
718-P: Long-Term Safety of Intranasal Insulin (INI) in Insulin-Dependent Type 2 Diabetes (T2DM-IDDM): A Safety Substudy of Memory Advancement by Intranasal Insulin in Type 2 …
LA Becerra, BG Mendez, F Khan, C Mantzoros, P Novak, V Lioutas, ...
Diabetes 70 (Supplement_1), 2021
2021
719-P: Caloric Intake, Appetite, and Body Composition Outcomes of Long-Term Intranasal Insulin (INI) Administration: A Substudy of the Memory Advancement by INI in Type 2 …
LA Becerra, F Khan, LH Ngo, V Novak, C MANTZOROS, ...
Diabetes 70 (Supplement_1), 2021
2021
STRATEGIES FOR NOSE-TO-BRAIN DRUG DELIVERY
RC Quispe, JA Trevino, F Khan, V Novak
系统目前无法执行此操作,请稍后再试。
文章 1–15